
Every private label bath product sold in the European Union must carry the mandatory label elements listed in Article 19 of Regulation (EC) No 1223/2009, and every product sold in the United States must meet FDA labeling rules now extended by the Modernization of Cosmetics Regulation Act (MoCRA). Get the label wrong and the consequences are practical, not theoretical: shipments held at customs, retailer onboarding stalled, marketplace listings blocked and, in the worst case, a recall. This guide sets out what belongs on the label in each market, how ingredient and allergen declarations work, which claims need evidence, and how to run a label artwork approval that protects your production timeline.
For buyers of bath bombs, body care, bath salts, gift sets and scented candles, the label is the single point where compliance, marketing and packaging art converge. It is also the element most often finished last. Factories can usually reprint a carton quickly; they cannot legally ship a cosmetic whose label misses a mandatory element, and neither can you. The stakes keep rising with the category: according to Grand View Research, the global luxury bath and body products market was valued at USD 19.0 billion in 2025 and is projected to reach USD 32.9 billion by 2033, a compound annual growth rate of 7.1%. More products competing on shelf means more scrutiny from regulators, retailers and consumers on the fine print. If you are still deciding between sourcing models, our overview of private label, white label and OEM/ODM explains who owns which compliance tasks in each model — and labeling sits with the brand side more often than buyers expect.
Article 19 of Regulation (EC) No 1223/2009 fixes the mandatory particulars for every cosmetic sold in the EU, bath bombs and body care included:
Before any of this appears on a label, the product must be notified through the EU Cosmetic Products Notification Portal (CPNP) by the responsible person. The European Commission's cosmetics legislation hub keeps the current legal texts and guidance in one place, and our plain-language guide to EU Regulation 1223/2009 for bath and body care brands walks through the parts that matter for this category.
Not everything on the label must be translated, but more than buyers expect: the nominal content, the durability information, the precautions and the product function must appear in an official language of each country where the product is sold. The INCI ingredient list stays international and is not translated. Where space is genuinely impracticable, some particulars may be carried on a leaflet, label, tape or card marked with the "open book" symbol — a fallback, not a default. Budget for the translation set of every launch market at the artwork stage, not after printing.
US cosmetic labeling rests on the Federal Food, Drug, and Cosmetic Act and the Fair Packaging and Labeling Act: the product identity, the net quantity of contents, the name and address of the manufacturer, packer or distributor, and a declared ingredient list, under the labeling regulations collected in FDA's cosmetics laws and regulations hub. MoCRA, signed in December 2022, did not replace those label rules but added the obligations around them: facility registration with biennial renewal, product listing by the responsible person with annual updates, documented safety substantiation, serious adverse event reporting within 15 business days, and mandatory recall authority. FDA's official MoCRA page tracks the implementation; by 2026 the agency reported more than 15,000 registered cosmetic facilities and over one million active product listings, a scale-up that makes registration and listing hygiene a practical entry condition for US retail.
One trap deserves its own paragraph: in the US, a bath or body product that claims to treat or prevent a condition — acne, eczema, muscle soreness — can cross from cosmetic into drug territory, which changes labeling, registration and claims substantiation entirely. Keep marketing copy on the moisturizing, cleansing and fragrance side of the line unless you are prepared to register an OTC drug.

The ingredient list is where most artwork rework happens, so treat it as data, not decoration. Ingredients are listed in descending order of weight; those below 1% may follow in any order; impurities and traces are not listed. The INCI names come from the final formula issued after sampling — never from a draft — which is one more reason the sampling and development process must be closed before artwork goes to print.
Fragrance allergens have their own regime. The EU has long required individual listing of 26 fragrance allergens when they exceed 0.001% in leave-on and 0.01% in rinse-off products. Commission Regulation (EU) 2023/1545 expanded that list by 56 additional allergens, aligned names and set transition dates. As of late 2026 the placement deadline has already passed: products newly placed on the EU market must carry the expanded declarations, while stock that complied earlier may still be made available until 31 July 2028. Bath bombs, shower steamers, bubble bars and bath salts are rinse-off formats, so the applicable threshold is 0.01% — but the declaration obligation now reaches far more essential oils and aroma compounds than before, which changes label copy for many natural-leaning lines.
Regulation (EU) No 655/2013 establishes six common criteria for cosmetic claims: legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. In practice that means the evidence file for a claim — consumer perception studies, instrumental measurements, dermatological testing — exists before the artwork is approved, not after a retailer asks. Absolute claims such as "chemical-free" and unpunctuated "hypoallergenic" claims are the first to fail review; "free-from" claims that disparage a lawful ingredient category are close behind. In the US the same discipline applies, with the added wrinkle that a claim can be truthful yet still drug-like. The cheapest compliance tool is a written claims matrix: every claim on the pack, its market, and the evidence reference that supports it.
Label problems are cheaper to catch in a checklist than in a warehouse. A workflow that consistently holds up looks like this:
Label artwork belongs in the first third of the project timeline, alongside packaging trials, not in the last two weeks. That is also the point at which a factory can still adjust component sizes or add a multilingual panel without touching the production schedule.
The same handful of errors causes most of the holds and rejections we see buyers hit:
No, but you must translate the elements the Regulation requires in the language of each sales market: nominal content, durability information, precautions and product function. The INCI list stays international. Many brands translate the full label as a matter of course because national inspectors read the whole panel, and some markets have additional national rules on top of the EU baseline.
The responsible person must be established inside the EU: the brand's own entity, the importer, or a distributor, or an authorized representative service appointed in writing. That name and EU address go on the label, and the same party files the CPNP notification and holds the Product Information File. A Chinese factory cannot appear in that role, however helpful its compliance team is.
If the product's shelf life exceeds 30 months, the label normally carries the period-after-opening symbol instead of a durability date — unless the PAO concept is irrelevant, as for single-use or aerosol formats. For rinse-off products the safety assessor decides the appropriate PAO based on stability and microbiological data; our guide to bath bomb shelf life and stability testing explains how those results are produced. Never print a PAO number that the stability file does not support.
Besthope Bath is a bath bomb, body care, gift set, bath salt and scented candle OEM/ODM manufacturer based in Quanzhou, China, producing under GMP-aligned processes with ISO 22716-referenced quality management and audited social compliance, including amfori BSCI and Walmart responsible-sourcing audits. Our teams issue final INCI ingredient lists with fragrance allergen declarations, support label copy matrices and artwork approval per destination market, and coordinate component and print timelines so labeling never becomes the reason an order slips. Send us your target markets and first-order volume, and our team will return a market-specific labeling checklist with your quotation.